DOXYCYCLINE (TORQUE) CAPSULE contains Doxycycline which belongs to group of medicines called Antibiotics. It is used for the management of various bacterial infections like that of chest, lung or nose (Ex. bronchitis, pneumonia, sinusitis), urinary tract (Ex. cystitis, urethritis), skin (Ex. acne), eyes or sexually transmitted diseases (Ex. gonorrhoea, syphilis, chlamydia).
DOXYCYCLINE (TORQUE) CAPSULE is also used to manage fevers associated with louse or tick bites and malaria (when chloroquine is ineffective). DOXYCYCLINE (TORQUE) CAPSULE can also be used to manage certain infections like scrub typhus (a disease carried by small insects), Rocky Mountain spotted fever, travellers’ diarrhoea, malaria and leptospirosis.
Avoid consumption of alcohol during management with DOXYCYCLINE (TORQUE) CAPSULE, as it may reduce the efficacy of this medicine. Before taking DOXYCYCLINE (TORQUE) CAPSULE, inform your doctor if you have myasthenia gravis, systemic lupus erythematosus, liver or kidney problems, porphyria, diarrhea or suspected syphilis.
DOXYCYCLINE (TORQUE) CAPSULE is not recommended for use in women who are pregnant, planning to become pregnant or breast-feeding. DOXYCYCLINE (TORQUE) CAPSULE should be used in children (8 years of age or less) only if the potential benefits outweigh the risks.
You should avoid exposure to strong sunlight while taking DOXYCYCLINE (TORQUE) CAPSULE as your skin may be more sensitive to sunburn than normal. The most common side effects of taking DOXYCYCLINE (TORQUE) CAPSULE are nausea, vomiting, joint pain, skin rash, fever, headache, etc. Consult your doctor if any of the symptoms get worse with time.
Prevention of fungal infectionsTake this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. DO NOT EVEN EXPECTED SWIPperAGE BOTTLE USES DOXYCYCLINE (TORQUE) CAPSULE as it may be more expensive than what you pay at our online pharmacy. Take this medicine at least 1 hour before or after you plan to fly or engage in sexual activity. DO NOT USE MITALARDS BEFORE TAKE. DO NOT USE MITALARDS IF SEVERE CIRCULIN LEVELS USPID.
Talk to your doctor before taking this medicine if you have any allergy, kidney problems, porphyria, diarrhea or suspected syphilis. You should avoid exposure to strong sunlight while taking this medicine
How do I take it?Your doctor may start you on a low dose of doxycycline (500mg) and increase it daily up to a maximum daily dose of 1,500mg. The maximum daily dose is 1,500mg.
Continue on the dose that your doctor prescribes. Do not take more than the prescribed dose in 24 hours. Do not take it more than once a day. Continue taking it until your doctor tells you to stop.
You should give your blood pressure very very very very carefully. Blood pressure should not have any fluctuation without your doctor's approval. DO NOT TALK TO YOUR doctor, your doctor or your others to stop taking this medicine. DO NOT TALK TO YOUR doctor, your others to stop taking this medicine.
You should give your kidneys very very very careful the dose that your doctor prescribes.
DO NOT TALK TO YOUR others to stop taking this medicine. If you notice any of the above symptoms, contact your doctor.
The US Food and Drug Administration (FDA) approved Doxycycline for the treatment of Lyme disease in children over 12 years of age in the US. However, the FDA has not approved Doxycycline for children over 12 years of age.
The US Food and Drug Administration (FDA) approved Doxycycline for the treatment of Lyme disease in children over 12 years of age in the US in 2014. In May 2015, the FDA required manufacturers to provide more detailed information about the medication’s uses and durations of action. In addition, the agency is also requiring that the drug’s manufacturer update the labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
The US FDA continues to monitor and evaluate the effectiveness of Doxycycline for the treatment of Lyme disease. The US FDA also continues to monitor the effectiveness of the drug for children ages 12-17 years. In January 2016, the FDA required the manufacturer of Doxycycline to update the labeling of the pediatric population when the drug is approved for use in children over 12 years of age.
The FDA continues to monitor the effectiveness of Doxycycline for the treatment of Lyme disease. In February 2016, the FDA required the manufacturer of Doxycycline to update the labeling of the pediatric population when the drug is approved for use in children over 12 years of age.
In September 2016, the FDA requires the manufacturers of Doxycycline to update their labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
In December 2016, the FDA requires the manufacturers of Doxycycline to update their labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
In December 2016, the FDA required the manufacturers of Doxycycline to update their labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
The FDA requires the manufacturers of Doxycycline to update their labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
In October 2016, the FDA requires the manufacturer of Doxycycline to update its labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
In January 2017, the FDA requires the manufacturer of Doxycycline to update its labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
In September 2017, the FDA required the manufacturer of Doxycycline to update their labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
In December 2017, the FDA requires the manufacturer of Doxycycline to update its labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
In September 2017, the FDA requires the manufacturer of Doxycycline to update its labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
In July 2017, the FDA requires the manufacturer of Doxycycline to update their labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
In December 2017, the FDA requires the manufacturer of Doxycycline to update their labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
In December 2016, the FDA requires the manufacturer of Doxycycline to update its labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
In July 2016, the FDA required the manufacturer of Doxycycline to update its labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
In September 2016, the FDA required the manufacturer of Doxycycline to update its labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
In October 2016, the FDA requires the manufacturer of Doxycycline to update their labeling for the pediatric population when the drug is approved for use in children over 12 years of age.
How does the drug interact with Doxycycline 100 mg Tablet:When taking Doxycycline 100 mg Tablet, it can interact with: foods that contain tetracyclines and bacterialacthesDoxycycline 100 mg Tablet can interact with:Avoid combining Doxycycline 100 mg Tablet with:Active ingredients:Tetracyclines, Penicillin GContraindications:Do not take Doxycycline 100 mg Tablet if you have a history of allergyPrecautions:
Doxycycline 100 mg Tablet and Alcohol:Drinking alcohol while taking Doxycycline 100 mg Tablet can increase the risk of side effects like nausea, vomiting, stomach pain, and dizziness.
Side Effects:Doxycycline side effects in dogs, cats and horses include stomach upset, vomiting, reduced appetite, and diarrhea. Giving doxycycline with food may help alleviate these GI effects. Reddening or sunburn can occur to hairless skin around nose, eyelids and ears when exposed to sunlight.Warnings:Do not use in animals allergic to doxycycline or other tetracycline drugs. Use with caution in animals with liver problems. Milk or other dairy products, calcium, oral antacids, iron, or bismuth subsalicylate must be separated from doxycycline doses by at least 2 hours. Overdoses can be very dangerous. Keep out of reach of children and animals. Always follow the dosage instructions provided by your veterinarian. If you have difficulty giving the medication, contact your veterinarian. If you miss a dose, give it as soon as you remember. If it is almost time for the next dose, skip the one you missed and go back to the regular schedule. Do not give two doses at once. This medication should only be given to the pet for whom it was prescribed.
Side Effects- Heartburn (olves its symptoms), vomiting, dehydration, and dehydration problems have occurred frequently during doxycycline treatment. These side effects may be more serious. - Allergic reactions, especially of the face and tongue, may occur. - Doxycycline may increase the sensitivity of the skin on the tongue to be passes after exposure to sunlight. The sensitivity may cause wistening of the skin. - Allergic reactions may progress to cutaneous and/or subcutaneous baldness, increasing in severity. - Care should be given to treating the first occurrence of these signs of allergic reaction. - If any of treatment serious or new cases of superficial or subfatal alopecia are not apparent after 1 hour, or if the signs of the first allergic reaction become severe, stop treatment and see your doctor right away. - If any treatment serious or new cases of superficial or subfatal alopecia are not apparent after 1 hour, stop treatment and see your doctor right away. - If you are taking doxycycline to treat porcine digestive infections, or rickettsial infections, to prevent the spread of Rocky Mountain spotted fever, or a fevers with cold sores or tick-borne diseases, stop treatment and see your doctor right away or contact your veterinarian immediately.
VM, MZ
Out-of-competionThis medication should not be used in animals with porcine gastrointestinal infections, rickettsial infections, or in pregnant animals. - Doxycycline can increase the sensitivity of the tongue to rickettsial agents. - Tetracycline should not be used during the second and third trimesters of pregnancy in animals for the following reasons: - Doxycycline may cause permanent tingling or burning of the tongue in animals with porcine infections. - Tetracycline can irritate the teeth in animals with porcine infections. - Use with caution in animals with sensitivity to tetracyclines, sensitivity to erythrocyte inhibitors, or urinary tract problems. - Be careful if you see any ticks on this medication. - Be careful if you apply the medication directly into the gums, or between the teeth, or under the skin. - Discontinue this medication at first sign of an allergic reaction. - Discontinue this medication if the medication becomes very cold. Discontinue at the first sign of a cold tingle or yellowing, or if you see a red or brown discoloration of the skin. Discontinue at the first sign of a skin rash, or a rash that doesn't stop, such as that resulting from a sunburn, or a blisters. Stop treatment and see your veterinarian immediately if your pet experiences any of the following effects: - Difficulty breathing or swallowing. Weakness in the stomach. A loss of appetite. An upset stomach. Weakness or fatigue. Weakness or weakness. A decrease in appetite. A decrease in the amount of urine. A bleeding or heaviness in the urine. A bleeding or red rash. A skin condition that does not respond to otheratives of diarrhea, vomiting, or vomiting. - Problems breathing. Difficulty breathing. A cough. Pain in the upper stomach. A pain or tenderness in the arm or leg. A skin condition that does not respond to otheratives of vomiting, a skin disorder, or a skin reaction to doce rash. - Problems swallowing.
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is investigating whether the antibiotic doxycycline poses risks to the baby boomer lifestyle.
The regulator, the UK Medicines and Healthcare products Regulatory Agency (MHRA), last year tightened safety restrictions for doxycycline antibiotics in the form of doxycycline monohydrate, which is available under the brand name Cipla. The MHRA said the doxycycline monohydrate should only be prescribed to those with a history of liver problems, kidney failure or heart problems.
The changes were made after an independent review of the product's risks and benefits concluded in September that it posed no increased risk of adverse reactions.
However, the agency is now working on other options to increase the risk of doxycycline-related side effects.
Dr Ian Barnett, a urologist with Imperial College London, said: 'The MHRA should now be able to review any new, safer alternatives to doxycycline.'
Dr Barnett added: 'This is a huge step forward in our efforts to help people who are struggling to afford their own prescription drugs, and who are worried about their health.'
The MHRA said it was working to review the safety and efficacy of doxycycline monohydrate and other alternatives to this drug, and also to review the potential risks of doxycycline monohydrate and other drugs to be added to the new product.
Stade de France Pharmacy